EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 33 / Numéro 4 (Avril 2017) Med Sci (Paris), 33 4 (2017) 404-409 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 33, Numéro 4, Avril 2017
Page(s) 404 - 409
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20173304010
Publié en ligne 12 mai 2017
  1. Lichtenstein P, Yip BH, Björk C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009 ; 373 : 234–239. [CrossRef] [PubMed] [Google Scholar]
  2. Benros ME, Eaton WW, Mortensen PB. The epidemiologic evidence linking autoimmune diseases and psychosis. Biol Psychiatry 2014 ; 75 : 300–306. [CrossRef] [PubMed] [Google Scholar]
  3. Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res 2016 ; 176 : 36–40. [CrossRef] [PubMed] [Google Scholar]
  4. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001 ; 409 : 860–921. [CrossRef] [PubMed] [Google Scholar]
  5. Bannert N, Kurth R. The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genom Hum Genet 2006 ; 7 : 149–173. [CrossRef] [Google Scholar]
  6. Weiss RA. The discovery of endogenous retroviruses. Retrovirology 2006 ; 3 : 67. [CrossRef] [PubMed] [Google Scholar]
  7. Belshaw R, Katzourakis A, Paces J, et al. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol 2005 ; 22 : 814–817. [CrossRef] [PubMed] [Google Scholar]
  8. Belshaw R, Pereira V, Katzourakis A, et al. Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci USA 2004 ; 101 : 4894–4899. [CrossRef] [Google Scholar]
  9. de Parseval N, Heidmann T. Human endogenous retroviruses: from infectious elements to human genes. Cytogenet Genome Res 2005 ; 110 : 318–332. [CrossRef] [PubMed] [Google Scholar]
  10. Marchi E, Kanapin A, Magiorkinis G, et al. Unfixed endogenous retroviral insertions in the human population. J Virol 2014 ; 88 : 9529–9537. [CrossRef] [PubMed] [Google Scholar]
  11. Buzdin A. Human-specific endogenous retroviruses. ScientificWorldJournal 2007 ; 7 : 1848–1868. [CrossRef] [PubMed] [Google Scholar]
  12. Kim HS. Genomic impact, chromosomal distribution and transcriptional regulation of HERV elements. Mol Cells 2012 ; 33 : 539–544. [CrossRef] [PubMed] [Google Scholar]
  13. Voisset C, Bouton O, Bedin F, et al. Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family. AIDS Res Hum Retrovir 2000 ; 16 : 731–740. [CrossRef] [Google Scholar]
  14. Wildschutte JH, Williams ZH, Montesion M, et al. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci USA 2016 ; 113 : E2326–E2334. [CrossRef] [Google Scholar]
  15. Wildschutte JH, Ram D, Subramanian R, et al. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls. Retrovirology 2014 ; 11 : 62. [CrossRef] [PubMed] [Google Scholar]
  16. Marchi E, Kanapin A, Byott M, et al. Neanderthal and Denisovan retroviruses in modern humans. Curr Biol CB 2013 ; 23 : R994–R995. [CrossRef] [Google Scholar]
  17. Blond JL, Besème F, Duret L, et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999 ; 73 : 1175–1185. [PubMed] [Google Scholar]
  18. Wenner M. Virology: the battle within. Nature 2008 ; 451 : 388–389. [CrossRef] [PubMed] [Google Scholar]
  19. Crow TJ. Is schizophrenia an infectious disease? Lancet 1983 ; 1 : 173–175. [CrossRef] [PubMed] [Google Scholar]
  20. Deb-Rinker P, Klempan TA, O’Reilly RL, et al. Molecular characterization of a MSRV-like sequence identified by RDA from monozygotic twin pairs discordant for schizophrenia. Genomics 1999 ; 61 : 133–144. [CrossRef] [PubMed] [Google Scholar]
  21. Frank O, Giehl M, Zheng C, et al. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virol 2005 ; 79 : 10890–10901. [CrossRef] [PubMed] [Google Scholar]
  22. Yolken RH, Karlsson H, Yee F, et al. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 2000 ; 31 : 193–199. [CrossRef] [PubMed] [Google Scholar]
  23. Weis S, Llenos IC, Sabunciyan S, et al. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J Neural Transm Vienna Austria 1996 2007 ; 114 : 645–655. [Google Scholar]
  24. Diem O, Schäffner M, Seifarth W, et al. Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells. PloS One 2012 ; 7 : e30054. [CrossRef] [PubMed] [Google Scholar]
  25. Karlsson H, Bachmann S, Schröder J, et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 2001 ; 98 : 4634–4639. [CrossRef] [Google Scholar]
  26. Karlsson H, Schröder J, Bachmann S, et al. HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol Psychiatry 2004 ; 9 : 12–13. [CrossRef] [PubMed] [Google Scholar]
  27. Yao Y, Schröder J, Nellåker C, et al. Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia. Genes Brain Behav 2008 ; 7 : 103–112. [PubMed] [Google Scholar]
  28. Perron H, Hamdani N, Faucard R, et al. Molecular characteristics of human endogenous retrovirus type-W in schizophrenia and bipolar disorder. Transl Psychiatry 2012 ; 2 : e201. [CrossRef] [PubMed] [Google Scholar]
  29. Huang W, Li S, Hu Y, et al. Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophr Bull 2011 ; 37 : 988–1000. [CrossRef] [PubMed] [Google Scholar]
  30. Perron H, Mekaoui L, Bernard C, et al. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry 2008 ; 64 : 1019–1023. [CrossRef] [PubMed] [Google Scholar]
  31. Perron H, Garson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative research group on multiple sclerosis. Proc Natl Acad Sci USA 1997 ; 94 : 7583–7588. [CrossRef] [Google Scholar]
  32. Dickerson F, Lillehoj E, Stallings C, et al. Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia. Schizophr Res 2012 ; 138 : 198–205. [CrossRef] [PubMed] [Google Scholar]
  33. Suntsova M, Gogvadze EV, Salozhin S, et al. Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH. Proc Natl Acad Sci USA 2013 ; 110 : 19472–19477. [CrossRef] [Google Scholar]
  34. Hegyi H. GABBR1 has a HERV-W LTR in its regulatory region – a possible implication for schizophrenia. Biol Direct 2013 ; 8 : 5. [CrossRef] [PubMed] [Google Scholar]
  35. Fatemi SH, Folsom TD, Thuras PD. Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res 2011 ; 128 : 37–43. [CrossRef] [PubMed] [Google Scholar]
  36. Mitchelmore C, Gede L. Brain Derived neurotrophic factor: epigenetic regulation in psychiatric disorders. Brain Res 2014 ; 1586 : 162–172. [CrossRef] [PubMed] [Google Scholar]
  37. Chang YH, Lee SY, Chen SL, et al. Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. J Affect Disord 2013 ; 151 : 967–972. [CrossRef] [PubMed] [Google Scholar]
  38. Young GR, Stoye JP, Kassiotis G. Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. BioEssays News Rev Mol Cell Dev Biol 2013 ; 35 : 794–803. [CrossRef] [Google Scholar]
  39. Kremer D, Schichel T, Förster M, et al. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann Neurol 2013 ; 74 : 721–732. [CrossRef] [PubMed] [Google Scholar]
  40. Najjar S, Pearlman DM. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 2015 ; 161 : 102–112. [CrossRef] [PubMed] [Google Scholar]
  41. Leboyer M, Tamouza R, Charron D, et al. Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface. World J Biol Psychiatry 2013 ; 14 : 80–90. [CrossRef] [PubMed] [Google Scholar]
  42. Blomström A, Karlsson H, Wicks S, et al. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring: a matched case-control study. Schizophr Res 2012 ; 140 : 25–30. [CrossRef] [PubMed] [Google Scholar]
  43. Sutterland AL, Fond G, Kuin A, et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand 2015 ; 132 : 161–179. [CrossRef] [PubMed] [Google Scholar]
  44. Frank O, Jones-Brando L, Leib-Mosch C, et al. Altered transcriptional activity of human endogenous retroviruses in neuroepithelial cells after infection with Toxoplasma gondii. J Infect Dis 2006 ; 194 : 1447–1449. [CrossRef] [PubMed] [Google Scholar]
  45. Grozeva D, Kirov G, Ivanov D, et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 2010 ; 67 : 318–327. [CrossRef] [PubMed] [Google Scholar]
  46. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008 ; 455 : 232–236. [CrossRef] [PubMed] [Google Scholar]
  47. International schizophrenia consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008 ; 455 : 237–241. [CrossRef] [PubMed] [Google Scholar]
  48. Bassett AS, Marshall CR, Lionel AC, et al. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet 2008 ; 17 : 4045–4053. [CrossRef] [PubMed] [Google Scholar]
  49. Petersen T, Møller-Larsen A, Ellermann-Eriksen S, et al. Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis. J Neuroimmunol 2012 ; 249 : 105–108. [CrossRef] [PubMed] [Google Scholar]
  50. Grüber L, Bunse T, Weidinger E, et al. Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients. J Clin Psychiatry 2014 ; 75 : 1266–1267. [Google Scholar]
  51. Derfuss T, Curtin F, Guebelin C, et al. A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients: a twelve month follow-up. J Neuroimmunol 2015 ; 285 : 68–70. [CrossRef] [PubMed] [Google Scholar]
  52. Curtin F, Perron H, Kromminga A, et al. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein. mAbs 2015 ; 7 : 265–275. [CrossRef] [PubMed] [Google Scholar]
  53. Kremer D, Förster M, Schichel T, et al. The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade. Mult Scler 2015 ; 21 : 1200–1203. [CrossRef] [PubMed] [Google Scholar]
  54. Medina J, Perron H. Séquences provenant d’éléments génétiques mobiles, face cachée du génome humain. Med Sci (Paris) 2017 ; 33 : 151–158. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  55. Medina J, Charvet B, Horvat B, et al. Des séquences rétrovirales endogènes dans le génome humain peuvent jouer un rôle physiologique ou pathologique. Med Sci (Paris) 2017 ; 33 : 397–403. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.